494 related articles for article (PubMed ID: 7932189)
1. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats.
Fornal CA; Litto WJ; Metzler CW; Marrosu F; Tada K; Jacobs BL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1345-58. PubMed ID: 7932189
[TBL] [Abstract][Full Text] [Related]
2. WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135.
Fornal CA; Metzler CW; Gallegos RA; Veasey SC; McCreary AC; Jacobs BL
J Pharmacol Exp Ther; 1996 Aug; 278(2):752-62. PubMed ID: 8768728
[TBL] [Abstract][Full Text] [Related]
3. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
Jolas T; Schreiber R; Laporte AM; Chastanet M; De Vry J; Glaser T; Adrien J; Hamon M
J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the serotonin1A receptor antagonist activity of WAY-100135 and spiperone.
Escandon NA; Zimmermann DC; McCall RB
J Pharmacol Exp Ther; 1994 Jan; 268(1):441-7. PubMed ID: 8301586
[TBL] [Abstract][Full Text] [Related]
5. Effects of the putative 5-hydroxytryptamine1A antagonists BMY 7378, NAN 190 and (-)-propranolol on serotonergic dorsal raphe unit activity in behaving cats.
Fornal CA; Marrosu F; Metzler CW; Tada K; Jacobs BL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1359-66. PubMed ID: 7932190
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing.
Martin LP; Jackson DM; Wallsten C; Waszczak BL
J Pharmacol Exp Ther; 1999 Feb; 288(2):820-6. PubMed ID: 9918594
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
8. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.
Gobert A; Lejeune F; Rivet JM; Audinot V; Newman-Tancredi A; Millan MJ
J Pharmacol Exp Ther; 1995 Jun; 273(3):1032-46. PubMed ID: 7791073
[TBL] [Abstract][Full Text] [Related]
10. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone.
Blier P; Lista A; De Montigny C
J Pharmacol Exp Ther; 1993 Apr; 265(1):7-15. PubMed ID: 8474032
[TBL] [Abstract][Full Text] [Related]
11. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
12. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
13. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon.
Kleven MS; Koek W
J Pharmacol Exp Ther; 1996 Feb; 276(2):388-97. PubMed ID: 8632301
[TBL] [Abstract][Full Text] [Related]
15. 5-HT-1A receptor-mediated modulation of medullary expiratory neurones in the cat.
Lalley PM; Bischoff AM; Richter DW
J Physiol; 1994 Apr; 476(1):117-30. PubMed ID: 8046627
[TBL] [Abstract][Full Text] [Related]
16. Studies on the neuronal circuits involved in the discriminative stimulus effects of 5-hydroxytryptamine1A receptor agonists in the rat.
Schreiber R; de Vry J
J Pharmacol Exp Ther; 1993 May; 265(2):572-9. PubMed ID: 8496807
[TBL] [Abstract][Full Text] [Related]
17. Functional topography of brain serotonergic pathways in the rat.
Hillegaart V
Acta Physiol Scand Suppl; 1991; 598():1-54. PubMed ID: 1832809
[TBL] [Abstract][Full Text] [Related]
18. The 5-HT1A receptor antagonist p-MPPI blocks 5-HT1A autoreceptors and increases dorsal raphe unit activity in awake cats.
Bjorvatn B; Fornal CA; MartÃn FJ; Metzler CW; Jacobs BL
Eur J Pharmacol; 1998 Sep; 356(2-3):167-78. PubMed ID: 9774246
[TBL] [Abstract][Full Text] [Related]
19. Effects of sleep deprivation on serotonergic neuronal activity in the dorsal raphe nucleus of the freely moving cat.
Gardner JP; Fornal CA; Jacobs BL
Neuropsychopharmacology; 1997 Aug; 17(2):72-81. PubMed ID: 9252982
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.
Trulson ME; Preussler DW; Trulson VM
J Pharmacol Exp Ther; 1984 Jan; 228(1):94-102. PubMed ID: 6694110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
